Medoctor, Inc. Receives US Patent
NAPA, Calif.--(BUSINESS WIRE)--Medoctor, Inc., received a US Patent entitled: “System and Method for Determining the Probable Existence of Disease." Medoctor’s operating technology is an Internet health assessment and personal record keeping system. Medoctor determines the probability of disease, thereby reducing medical errors and wasteful use of healthcare resources.
“System and Method for Determining the Probable Existence of Disease.”
The Medoctor system utilizes mathematical algorithms like those used in the hit TV show “Numbers”. While the TV show solves crime mysteries, Medoctor solves medical mysteries, to the satisfaction of the United States Patent Office and the World Health Organization (WHO).
Developed by a team of 25 medical researchers in Santa Rosa, California, Medoctor performs a differential diagnosis (DDX) of over 830 diseases and conditions in five languages - English, Spanish, French, German and Italian, on its website www.medoctor.com. Each Medoctor user creates a personal electronic health record.
The American Telemedicine Association’s paper, “Telemedicine and Federal Policy”, promotes the use of “telemedicine triage” stations in community centers and pharmacies. Medoctor can be deployed in clinics, like those being developed by Wal-Mart; CVS, Walgreen and Rite-Aid pharmacies, to provide for the millions without health insurance.
A study by Sonoma County, California found that 64% of emergency room visits can be handled in less-costly, non-emergency settings. Hospitals absorb unnecessary ER costs in their community service budgets. Medoctor’s triage system could save hospitals and government agencies billions of dollars annually.
Governments have long searched for an affordable health record-keeping solution. Medoctor combines a diagnostic tool with a personal health record, helping individuals, healthcare payers and providers alike. The United Nations’ International Telecommunication Union (ITU) funded a pilot project of Medoctor in rural Africa.
Medoctor will develop strategic alliances with pharmaceutical companies to reduce development costs of new drugs and speed FDA approval. Medoctor’s databases provide efficient means of collecting data. The totality of the data collected will be valuable in biotech research. A license agreement is being negotiated with a major wireless company to adapt Medoctor for worldwide use on cell phones.
There are some 47,000,000+ people in the USA without health insurance. Medoctor is an affordable solution for this unacceptable problem. Medoctor provides a basic diagnosis to allow everyone an opportunity to know what ails them, as well as, to record all data as an electronic health record for physicians.